<DOC>
	<DOCNO>NCT02858050</DOCNO>
	<brief_summary>The study look real-times adhernce monitor Portal-724 MEMS cap . It integrate medication bottle , Smart Cap , Pill Dispenser , Embedded Computer , Embedded Cellular Modem Tamper Proof apparatus . This device capable transmitting pill dispense event patient 's home Cloud Cellular IP network . The transmission do real time cellular coverage 1-bar , cell available signal threshold , device Store-and-Forward feature automatically activated.. Patient randmized real-time monitoring monitoring data download monthly study visit take hepatitis C medication</brief_summary>
	<brief_title>Portal-724 MEMS Medication Adherence Patients Taking HCV Medications</brief_title>
	<detailed_description />
	<criteria>1 . Male female 18 year old . 2 . HCV treatment naïve HCV trreatment experience 3 . HCV RNA PCR &gt; 10,000 IU/L 4 . Confirmed infection Hepatitis C virus ( HCV ) HCV serum antibody assay HCV Ribonucleic Acid ( RNA ) Polymerase Chain Reaction ( PCR ) Confirmed chronicity 2 PCR 's 6 month apart . 5 . Patients HCV Genotype 1 , 4 6 . Patients candidate treatment HCV oral DirectActing Agents ( DAA ) 7. understand study procedure , alternative treatment available , risk involve study , voluntarily agree participate give write informed consent 1 . Patient willing sign write informed consent 2 . Patients deem suitable HCV treatment deem treat physician liver center 3 . Patients decompensated liver cirrhosis , define follow : 1 . Liver biopsy within last year show Scheuer Stage 4 transient elastography ( Fibroscan® ) last year read &gt; 12.5 kPa ; AND 2 . Any clinical sign hepatic decompensation ascites ( fluid abdomen ) , jaundice ( yellow eye skin ) , esophageal varix bleed ( enlarged vein esophagus see endoscopy ) hepatic encephalopathy ( tremor , confusion , sleepiness ) 4 . CoInfection Hepatitis B virus 5 . Any liver disease nonHCV etiology Hemochromatosis , Wilson 's Disease , Alcoholic liver disease NonAlcoholic SteatoHepatitis ( NASH ) 6 . Hepatocellular carcinoma malignancy 7 . Untreated psychiatric condition major depression , schizophrenia , bipolar disorder opinion Principal Investigator interfere protocol visit and/or procedures 8 . Current untreated substance abuse ( cocaine , opiates , alcohol , marijuana , recreational drug , control substance ) 9 . Patient pregnant breastfeeding . 10 . Patients unwilling use cellular phone 11 . Patients unwilling follow specific instruction medication intake 12 . Patient follow condition : Organ transplant ( include hematopoietic stem cell transplant ) cornea hair . Poor venous access precludes routine peripheral blood sampling require trial . History gastric surgery ( e.g. , staple , bypass ) subject history malabsorption disorder ( e.g. , celiac sprue disease ) . History medical/surgical condition result hospitalization within 3 month prior enrollment , minor elective procedure Medical/surgical condition may result need hospitalization period study medical condition requiring , likely require , chronic systemic administration corticosteroid , TNF antagonists , immunosuppressant drug course trial 13. exclusionary laboratory value list : Noncirrhotic/Cirrhotic Subjects Creatinine clearance &lt; 50 mL/min Hemoglobin &lt; 9.5 g/dL male female subject Platelets &lt; 50 x 103/μL serum albumin &lt; 3.0 g/dL INR &gt; 1.7 , unless subject stable INR anticoagulant regimen . HbA1c &gt; 10 % ALT &gt; 10XULN AST &gt; 10XULN 14. immediate family member ( e.g. , spouse , parent/legal guardian , sibling child ) investigational site sponsor staff directly involve trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>